Skip to main content
Premium Trial:

Request an Annual Quote

NanoInk Launches Life Sciences Division

NEW YORK (GenomeWeb News) – Nanotechnology firm NanoInk today said that it has launched a new division called NanoBioDiscovery that will focus on supplying technologies for biomarker research and drug discovery.
 
The Skokie, Ill.-based firm said that the new division will use its Dip Pen Nanolithography nanofabrication techniques and detection systems to produce assays for protein discovery and identification. It believes its technology can provide researchers with enhanced reaction kinetics and assay cost savings.
 
The division also will have a contract research group to perform experiments for customers.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.